Results 141 to 150 of about 30,028 (235)

Evaluation of Genome in Early Familial Coronary Artery Disease: A Case Report

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, 2019
Background and Objectives: Coronary artery diseases (CAD) are the most common cause of death in Iran and worldwide. Myocardial infarction (MI) is a complex multifactorial and the most severe type of CAD.
Mohammad Javad Ghorbani, Nematollah Razmi, Seyed Mohammad Bagher Tabei, Mohammad Javad Zibaeenezhad, Hamid Reza Goodarzi   +4 more
doaj  

Effect of causative genetic variants on atherosclerotic cardiovascular disease in heterozygous familial hypercholesterolemia patients. [PDF]

Front Cardiovasc Med, 2023
Matta A, Rabès JP, Taraszkiewicz D, Carrié D, Roncalli J, Ferrières J.   +5 more
europepmc   +1 more source

Implementation of Novel Lipid Therapies in a Refractory Heterozygous Familial Hypercholesterolemia Patient With Atherosclerotic Disease. [PDF]

JACC Case Rep, 2022
Weintraub SF, Schillow JA, Azari BM, Hirsh BJ.   +3 more
europepmc   +1 more source

Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia. [PDF]

Atheroscler Plus, 2022
Ferrières J, Farnier M, Bruckert E, Vimont A, Durlach V, Ferrari E, Gallo A, Boccara F, Ferrières D, Béliard S, French FH Registry group: French REgistry of Familial hypERCHOLesterolemia (REFERCHOL).   +10 more
europepmc   +1 more source

Whole Exome Sequencing Insufficient for a Definitive Diagnosis of a Patient with Compound Heterozygous Familial Hypercholesterolemia. [PDF]

Intern Med, 2022
Okada H, Tada H, Nomura A, Nohara A, Okeie K, Nozue T, Michishita I, Takamura M, Takemura H, Kawashiri MA.   +9 more
europepmc   +1 more source

Characterization of Polyvascular Disease in Heterozygous Familial Hypercholesterolemia: Its Association With Circulating Lipoprotein(a) Levels. [PDF]

J Am Heart Assoc, 2022
Funabashi S, Kataoka Y, Hori M, Ogura M, Doi T, Noguchi T, Harada-Shiba M.   +6 more
europepmc   +1 more source

Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis

, 2007
Bestwick, JP, Wald, NJ, Wald, DS
core   +1 more source

Non-Responder to Inclisiran and Evolocumab-A Female Patient with Heterozygous Familial Hypercholesterolemia and Statin Intolerance. [PDF]

Diseases
Muszyński P, Chlabicz M, Kruszyńska J, Wilk-Śledziewska K, Kazberuk P, Musiałowska D, Groth M, Dudzińska K.   +7 more
europepmc   +1 more source

Estimated Yield of Screening for Heterozygous Familial Hypercholesterolemia With and Without Genetic Testing in US Adults. [PDF]

J Am Heart Assoc, 2022
Bellows BK, Khera AV, Zhang Y, Ruiz-Negrón N, Stoddard HM, Wong JB, Kazi DS, de Ferranti SD, Moran AE.   +8 more
europepmc   +1 more source

CO18 | Relationship between gut permeability and PCSK9 in heterozygous familial hypercholesterolemia

Bleeding, Thrombosis and Vascular Biology
Background: Gut dysbiosis is a major determinant of low-grade endotoxaemia via dysfunction of the intestinal barrier scaffold, which is a prerequisite for Lipopolysaccharide (LPS) translocation into the systemic circulation.
doaj   +1 more source